Second-generation antidepressant
(Redirected from
Second-generation antidepressants
) | This article needs additional citations for verification. (May 2017) |
| Second-generation antidepressant | |
|---|---|
| Drug class | |
| Class identifiers | |
| Use | Depressive disorders |
| External links | |
| MeSH | D018687 |
| Legal status | |
| In Wikidata | |
The second-generation antidepressants are a class of
pharmacological effect
. As a consequence, there is some controversy over which treatments actually belong in this class.
The term "third generation antidepressant" is sometimes used to refer to newer antidepressants,[1] from the 1990s and 2000s, often selective serotonin reuptake inhibitors (SSRIs) such as; fluoxetine (Prozac), paroxetine (Paxil) and sertraline (Zoloft), as well as some non-SSRI antidepressants such as mirtazapine, nefazodone, venlafaxine, duloxetine and reboxetine. However, this usage is not universal.
Examples
This list is not exhaustive, and different sources vary upon which items should be considered second-generation.
- Amineptine
- Amoxapine
- Bupropion
- Iprindole
- Maprotiline
- Medifoxamine
- Mianserin
- Nomifensine
- Tianeptine
- Trazodone
- Venlafaxine
- Viloxazine
See also
- Atypical antidepressant
- Development and discovery of SSRI drugs
- Pharmacology of antidepressants
- Tricyclic antidepressant
- Tetracyclic antidepressant
- Serotonin–norepinephrine reuptake inhibitor
- Serotonin antagonist and reuptake inhibitor
- Noradrenergic and specific serotonergic antidepressant
References
- S2CID 39029287.
External links
- Second-Generation+Antidepressive+Agents at the U.S. National Library of Medicine Medical Subject Headings (MeSH)
- Diagrams at toxlab.co.uk
- Overview at sagepub.com
- Overview at psyweb.com
- Overview at sciencedaily.com
- Overview at sabryabdelfattah.tripod.com